Wikisage, the free encyclopedia of the second generation, is digital heritage
Topiramate: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 5: | Line 5: | ||
==Links== | ==Links== | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307870/pdf/main.pdf Topiramate-induced periodic limb movement disorders] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307870/pdf/main.pdf Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy] | ||
<references/> | <references/> | ||
Revision as of 03:02, 18 April 2016
topiramate compared to phenobarbital result better effect on, both partial, generalized [1] QudexyTM is an extended release form of topiramate and could be use in patient unable to swalow intact capsules [2]
Links
Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy
- ↑ Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital
- ↑ http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract